Roundtable: Building Investor Confidence Through Scalable Donor Strategies in Allogeneic Cell Therapy
Time: 2:30 pm
day: Conference Day Two
Details:
- Earning trust by showing control over biological variability with a proactive, data-informed donor strategy
- Linking donor sourcing strategies and metrics directly to the ability to reduce batch failure, lower cost of goods, and deliver on trial milestones
- Developing meaningful collaboration between sponsors and suppliers to build a robust donor strategy
